Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Return on Equity (2020 - 2025)

Historic Return on Equity for Ovid Therapeutics (OVID) over the last 6 years, with Q3 2025 value amounting to 0.72%.

  • Ovid Therapeutics' Return on Equity fell 3300.0% to 0.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72%, marking a year-over-year decrease of 3300.0%. This contributed to the annual value of 0.34% for FY2024, which is 1400.0% up from last year.
  • As of Q3 2025, Ovid Therapeutics' Return on Equity stood at 0.72%, which was down 3300.0% from 0.66% recorded in Q2 2025.
  • Ovid Therapeutics' 5-year Return on Equity high stood at 0.87% for Q1 2021, and its period low was 0.72% during Q3 2025.
  • Over the past 5 years, Ovid Therapeutics' median Return on Equity value was 0.4% (recorded in 2022), while the average stood at 0.23%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 21600bps in 2021, then plummeted by -12700bps in 2022.
  • Ovid Therapeutics' Return on Equity (Quarter) stood at 0.65% in 2021, then tumbled by -161bps to 0.39% in 2022, then plummeted by -40bps to 0.55% in 2023, then surged by 34bps to 0.37% in 2024, then plummeted by -98bps to 0.72% in 2025.
  • Its last three reported values are 0.72% in Q3 2025, 0.66% for Q2 2025, and 0.39% during Q1 2025.